ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,630.50
0.57%
S&P ASX All Technology
3,015.80
1.46%
Brent Oil
83.715
0.10%
US Dollar vs AUD
1.51991
-0.13%
Bitcoin
59,669.20
0.93%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. BioMarin Pharmaceutical Inc (BMRN)

  7. BioMarin Pharmaceutical Inc (BMRN) News

BMRN BioMarin Pharmaceutical Inc

83.80
0.47 (0.56%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
BioMarin Pharmaceutical Inc BMRN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.47 0.56% 83.80 06:48:06
Open Price Low Price High Price Close Price Previous Close
82.91 81.43 85.035 83.80 83.33
more quote information »

Recent News

Date Time Source Heading
25/4/202406:03PRNUSBioMarin Reports Record Financial Results for the First..
10/4/202422:00PRNUSBioMarin to Host First Quarter 2024 Financial Results..
12/3/202423:30PRNUSNew Data to be Presented for BioMarin's VOXZOGO®..
08/3/202410:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202409:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202409:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202400:30PRNUSBioMarin Announces Appointment of Cristin Hubbard as Chief..
07/3/202404:04EDGAR2Form 144 - Report of proposed sale of securities
06/3/202408:17EDGAR2Form 144 - Report of proposed sale of securities
06/3/202406:41EDGAR2Form 144 - Report of proposed sale of securities
06/3/202404:04EDGAR2Form 144 - Report of proposed sale of securities
02/3/202401:00PRNUSBioMarin Scheduled to Participate in March Investor..
01/3/202409:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202409:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202409:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202409:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202409:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202409:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202402:35EDGAR2Form 144 - Report of proposed sale of securities
27/2/202405:34EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/2/202408:06EDGAR2Form 8-K - Current report
23/2/202408:03PRNUSBioMarin Reports Record Financial Results for the Fourth..
13/2/202409:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202407:24EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
13/2/202407:04EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
10/2/202409:46EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/2/202402:36EDGAR2Form 144 - Report of proposed sale of securities
09/2/202401:46EDGAR2Form 144 - Report of proposed sale of securities
09/2/202400:00PRNUSBioMarin to Host Fourth Quarter and Full-Year 2023 Financial..
07/2/202400:30PRNUSBioMarin to Present ROCTAVIAN™ (valoctocogene..
27/1/202403:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202411:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202408:06EDGAR2Form 8-K - Current report
12/1/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202402:09EDGAR2Form 144 - Report of proposed sale of securities
10/1/202403:48EDGAR2Form 144 - Report of proposed sale of securities
04/1/202400:00PRNUSBioMarin to Present at the 42nd Annual J.P. Morgan..
29/12/202305:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202305:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/12/202305:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202305:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/12/202305:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202305:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/12/202309:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202301:57EDGAR2Form 144 - Report of proposed sale of securities
21/12/202309:22EDGAR2Form 8-K - Current report
21/12/202308:05PRNUSBioMarin Announces Governance Enhancements and Value..
15/12/202310:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202303:49EDGAR2Form 144 - Report of proposed sale of securities
13/12/202311:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
BMRN
BioMarin Pharmaceutical
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved